Teva Pharmaceutical Industries L (NYSE: TEVA) stock suffered a major decline of -13.9% on 1/29/25. The shares closed at $18.54. Moreover, this decline was accompanied by exceptionally high trading volume at 378% of normal. The stock has been strong relative to the market over the last nine months but has declined -15.0% during the last week.
Current PriceTarget Research Rating
Teva Pharmaceutical Industries L has a current Value Trend Rating of B (Positive). This rating combines inconsistent signals from two proprietary PTR measures of a stock’s attractiveness. Teva Pharmaceutical Industries L has a neutral Appreciation Score of 56 but a good Power Rating of 73, and the Positive Value Trend Rating results.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of B. This review will be completed in the next several days.
Be the first to comment